Measuring force of infection and vaccine effects on transmission stages in clinical trials of experimental malaria vaccines

by Felger Ingrid, Genton Blaise, Beck Hans-Peter, Smith Tom
Published 2012-10-01

Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.

by Mohammad Zeeshan, Mohammad Tauqeer Alam, Sumiti Vinayak, Hema Bora, Rupesh Kumar Tyagi, Mohd Shoeb Alam, Vandana Choudhary, Pooja Mittra, Vanshika Lumb, Praveen Kumar Bharti, Venkatachalam Udhayakumar, Neeru Singh, Vidhan Jain, Pushpendra Pal Singh, Yagya Dutta Sharma
Published 2012-01-01

RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials

by Machteld van den Berg, Bernhards Ogutu, Nelson K. Sewankambo, Nikola Biller-Andorno, Marcel Tanner
Published 2019-05-01

A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies

by Yenni Yusuf, Yenni Yusuf, Tatsuya Yoshii, Mitsuhiro Iyori, Hiroaki Mizukami, Shinya Fukumoto, Daisuke S. Yamamoto, Talha Bin Emran, Fitri Amelia, Ashekul Islam, Intan Syafira, Shigeto Yoshida
Published 2019-10-01

Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail Challenge.

by Alexander Boes, Holger Spiegel, Nadja Voepel, Gueven Edgue, Veronique Beiss, Stephanie Kapelski, Rolf Fendel, Matthias Scheuermayer, Gabriele Pradel, Judith M Bolscher, Marije C Behet, Koen J Dechering, Cornelus C Hermsen, Robert W Sauerwein, Stefan Schillberg, Andreas Reimann, Rainer Fischer
Published 2015-01-01

Identification and characterization of protective CD8+ T‐epitopes in a malaria vaccine candidate SLTRiP

by Afshana Quadiri, Inderjeet Kalia, Mohammad Kashif, Agam P. Singh
Published 2020-03-01

Breakthroughs towards a malaria vaccine Avanços rumo à vacina contra a malária

by Ruth Sonntag Nussenzweig
Published 2011-06-01

Toward improved blood-stage malaria vaccines : characterising the underlying immunogenicity of vaccine adjuvants and vectors

by Cassan, Simone de
Published 2011

Willingness to Pay for Childhood Malaria Vaccine Among Caregivers of Under-Five Children in Northwest Ethiopia

by Wagnew Y, Hagos T, Weldegerima B, Debie A
Published 2021-03-01

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy

by Carlota Dobaño, Hèctor Sanz, Hermann Sorgho, David Dosoo, Maximilian Mpina, Itziar Ubillos, Ruth Aguilar, Tom Ford, Núria Díez-Padrisa, Nana Aba Williams, Aintzane Ayestaran, Ousmane Traore, Augusto J. Nhabomba, Chenjerai Jairoce, John Waitumbi, Selidji Todagbe Agnandji, Simon Kariuki, Salim Abdulla, John J. Aponte, Benjamin Mordmüller, Kwaku Poku Asante, Seth Owusu-Agyei, Halidou Tinto, Joseph J. Campo, Gemma Moncunill, Ben Gyan, Clarissa Valim, Claudia Daubenberger
Published 2019-05-01

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

by Frank Lennartz, Florian Brod, Rebecca Dabbs, Kazutoyo Miura, David Mekhaiel, Arianna Marini, Matthijs M. Jore, Max M. Søgaard, Thomas Jørgensen, Willem A. de Jongh, Robert W. Sauerwein, Carole A. Long, Sumi Biswas, Matthew K. Higgins
Published 2018-09-01

The TatD-like DNase of Plasmodium is a virulence factor and a potential malaria vaccine candidate

by Zhiguang Chang, Ning Jiang, Yuanyuan Zhang, Huijun Lu, Jigang Yin, Mats Wahlgren, Xunjia Cheng, Yaming Cao, Qijun Chen
Published 2016-05-01

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.

by Jo-Anne Chan, David Wetzel, Linda Reiling, Kazutoyo Miura, Damien R Drew, Paul R Gilson, David A Anderson, Jack S Richards, Carole A Long, Manfred Suckow, Volker Jenzelewski, Takafumi Tsuboi, Michelle J Boyle, Michael Piontek, James G Beeson
Published 2019-01-01

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries

by Christophe Sauboin, Laure-Anne Van Bellinghen, Nicolas Van De Velde, Ilse Van Vlaenderen
Published 2019-12-01

Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.

by Jedidah Mwacharo, Susanna J Dunachie, Oscar Kai, Adrian V S Hill, Philip Bejon, Helen A Fletcher
Published 2009-12-01

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

by Fiona M Thompson, David W Porter, Shinji L Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L Williams, Robert Sinden, Sarah C Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V S Hill
Published 2008-01-01

MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.

by Susanna J Dunachie, Tamara Berthoud, Sheila M Keating, Adrian V S Hill, Helen A Fletcher
Published 2010-09-01

Exploring the Use of a General Equilibrium Method to Assess the Value of a Malaria Vaccine: An Application to Ghana

by Erez Yerushalmi, Priscillia Hunt, Stijn Hoorens, Christophe Sauboin, Richard Smith
Published 2019-12-01

The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design

by Rachel D. Curd, Berry Birdsall, Madhusudan Kadekoppala, Solabomi A. Ogun, Geoffrey Kelly, Anthony A. Holder
Published 2014-01-01

Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.

by Alassane Dicko, Issaka Sagara, Ruth D Ellis, Kazutoyo Miura, Ousmane Guindo, Beh Kamate, Moussa Sogoba, Mohamed Balla Niambelé, Mady Sissoko, Mounirou Baby, Amagana Dolo, Gregory E D Mullen, Michael P Fay, Mark Pierce, Dapa A Diallo, Allan Saul, Louis H Miller, Ogobara K Doumbo
Published 2008-02-01